Literature DB >> 29934877

Clinical outcomes of childhood craniopharyngioma: can we do better?

Susan M Webb1.   

Abstract

Mesh：

Year:  2018        PMID： 29934877     DOI： 10.1007/s12020-018-1654-9

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  11 in total

1.  Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence.

Authors:  Hermann L Müller; Ursel Gebhardt; Andreas Faldum; Angela Emser; Nicole Etavard-Gorris; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-05-12       Impact factor: 1.475

2.  Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.

Authors:  Susan M Webb; Christian J Strasburger; Daojun Mo; Mark L Hartman; Shlomo Melmed; Heike Jung; Werner F Blum; Andrea F Attanasio
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

3.  Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.

Authors:  Kerstin Heinks; Svenja Boekhoff; Anika Hoffmann; Monika Warmuth-Metz; Maria Eveslage; Junxiang Peng; Gabriele Calaminus; Hermann L Müller
Journal:  Endocrine       Date:  2017-12-11       Impact factor: 3.633

Review 4.  High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.

Authors:  Alberto M Pereira; Eva M Schmid; Pieter J Schutte; Joan H C Voormolen; Nienke R Biermasz; Sjoerd W van Thiel; Eleonora P M Corssmit; Jan W A Smit; Ferdinand Roelfsema; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2005-02       Impact factor: 3.478

5.  [Munster Heidelberg Abilities Scale--a measuring instrument for global comparison of illness sequelae].

Authors:  J E Wolff; E Däumling; A Dirksen; A Dabrock; M Hartmann; H Jürgens
Journal:  Klin Padiatr       Date:  1996 Sep-Oct       Impact factor: 1.349

6.  Quality of life in patients after long-term biochemical cure of Cushing's disease.

Authors:  M O van Aken; A M Pereira; N R Biermasz; S W van Thiel; H C Hoftijzer; J W A Smit; F Roelfsema; S W J Lamberts; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

7.  Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.

Authors:  Agatha A van der Klaauw; Marleen Kars; Nienke R Biermasz; Ferdinand Roelfsema; Olaf M Dekkers; Eleonora P Corssmit; Maarten O van Aken; Bas Havekes; Alberto M Pereira; Hanno Pijl; Johannes W Smit; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-29       Impact factor: 3.478

8.  Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations.

Authors:  Maria Koltowska-Häggström; Anders F Mattsson; Stephen M Shalet
Journal:  Eur J Endocrinol       Date:  2009-08-14       Impact factor: 6.664

9.  Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.

Authors:  Tamara Wexler; Lindsay Gunnell; Zehra Omer; Karen Kuhlthau; Catherine Beauregard; Gwenda Graham; Andrea L Utz; Beverly Biller; Lisa Nachtigall; Jay Loeffler; Brooke Swearingen; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186
View more
  1 in total

Review 1.  Excess mortality after craniopharyngioma treatment: are we making progress?

Authors:  Nidan Qiao
Journal:  Endocrine       Date:  2018-12-19       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.